2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine

C197H199Cl3N16O20 — CID 158601935

IUPAC2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine
SMILESC/C=C/c1ccc(OC)cc1COc1ccc(-c2nc3cc(C(=O)O)ccc3n2C2CCCCC2)cc1.CC(=O)Nc1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CCCNc1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CCCc1ccc(OC)cc1COc1ccc(-c2nc3cc(C(=O)O)ccc3n2C2CCCCC2)cc1.CNC(=O)c1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CNC(C)c1ccc2c(c1)nc(-c1ccc(OCc3ccccc3)cc1)n2C1CCCCC1
InChIInChI=1S/C36H36ClN3O3.2C35H32ClN3O4.C31H34N2O4.C31H32N2O4.C29H33N3O/c1-2-20-38-29-15-18-32(24-8-13-28(37)14-9-24)27(21-29)23-43-31-16-10-25(11-17-31)35-39-33-22-26(36(41)42)12-19-34(33)40(35)30-6-4-3-5-7-30;1-37-34(40)24-11-17-30(22-7-13-27(36)14-8-22)26(19-24)21-43-29-15-9-23(10-16-29)33-38-31-20-25(35(41)42)12-18-32(31)39(33)28-5-3-2-4-6-28;1-22(40)37-28-14-17-31(23-7-12-27(36)13-8-23)26(19-28)21-43-30-15-9-24(10-16-30)34-38-32-20-25(35(41)42)11-18-33(32)39(34)29-5-3-2-4-6-29;2*1-3-7-21-10-16-27(36-2)18-24(21)20-37-26-14-11-22(12-15-26)30-32-28-19-23(31(34)35)13-17-29(28)33(30)25-8-5-4-6-9-25;1-21(30-2)24-15-18-28-27(19-24)31-29(32(28)25-11-7-4-8-12-25)23-13-16-26(17-14-23)33-20-22-9-5-3-6-10-22/h8-19,21-22,30,38H,2-7,20,23H2,1H3,(H,41,42);7-20,28H,2-6,21H2,1H3,(H,37,40)(H,41,42);7-20,29H,2-6,21H2,1H3,(H,37,40)(H,41,42);10-19,25H,3-9,20H2,1-2H3,(H,34,35);3,7,10-19,25H,4-6,8-9,20H2,1-2H3,(H,34,35);3,5-6,9-10,13-19,21,25,30H,4,7-8,11-12,20H2,1-2H3/b;;;;7-3+;
InChIKeyHVSWCARGAVCSRA-SADIJRGMSA-N
MW3217.21 g/mol
LogP48.60
Rot. Bonds50

About 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine

2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine (PubChem CID 158601935) has the molecular formula C197H199Cl3N16O20 and a molecular weight of 3217.21 g/mol. Its IUPAC name is 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine.

Molecular Properties

Compound Name2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine
PubChem CID158601935
Molecular FormulaC197H199Cl3N16O20
Molecular Weight3217.21 g/mol
Exact Mass3213.41
IUPAC Name2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine
SMILESC/C=C/c1ccc(OC)cc1COc1ccc(-c2nc3cc(C(=O)O)ccc3n2C2CCCCC2)cc1.CC(=O)Nc1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CCCNc1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CCCc1ccc(OC)cc1COc1ccc(-c2nc3cc(C(=O)O)ccc3n2C2CCCCC2)cc1.CNC(=O)c1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CNC(C)c1ccc2c(c1)nc(-c1ccc(OCc3ccccc3)cc1)n2C1CCCCC1
InChIInChI=1S/C36H36ClN3O3.2C35H32ClN3O4.C31H34N2O4.C31H32N2O4.C29H33N3O/c1-2-20-38-29-15-18-32(24-8-13-28(37)14-9-24)27(21-29)23-43-31-16-10-25(11-17-31)35-39-33-22-26(36(41)42)12-19-34(33)40(35)30-6-4-3-5-7-30;1-37-34(40)24-11-17-30(22-7-13-27(36)14-8-22)26(19-24)21-43-29-15-9-23(10-16-29)33-38-31-20-25(35(41)42)12-18-32(31)39(33)28-5-3-2-4-6-28;1-22(40)37-28-14-17-31(23-7-12-27(36)13-8-23)26(19-28)21-43-30-15-9-24(10-16-30)34-38-32-20-25(35(41)42)11-18-33(32)39(34)29-5-3-2-4-6-29;2*1-3-7-21-10-16-27(36-2)18-24(21)20-37-26-14-11-22(12-15-26)30-32-28-19-23(31(34)35)13-17-29(28)33(30)25-8-5-4-6-9-25;1-21(30-2)24-15-18-28-27(19-24)31-29(32(28)25-11-7-4-8-12-25)23-13-16-26(17-14-23)33-20-22-9-5-3-6-10-22/h8-19,21-22,30,38H,2-7,20,23H2,1H3,(H,41,42);7-20,28H,2-6,21H2,1H3,(H,37,40)(H,41,42);7-20,29H,2-6,21H2,1H3,(H,37,40)(H,41,42);10-19,25H,3-9,20H2,1-2H3,(H,34,35);3,7,10-19,25H,4-6,8-9,20H2,1-2H3,(H,34,35);3,5-6,9-10,13-19,21,25,30H,4,7-8,11-12,20H2,1-2H3/b;;;;7-3+;
InChIKeyHVSWCARGAVCSRA-SADIJRGMSA-N
XLogP48.60
TPSA449.52 Ų
H-Bond Donors9
H-Bond Acceptors29
Rotatable Bonds50
Heavy Atoms236
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003217.21
LogP ≤ 548.60
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1029

Analyze 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine?
The IUPAC name of 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine (CID 158601935) is 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine.
What is the SMILES notation for 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine?
The canonical SMILES for 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine is C/C=C/c1ccc(OC)cc1COc1ccc(-c2nc3cc(C(=O)O)ccc3n2C2CCCCC2)cc1.CC(=O)Nc1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CCCNc1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CCCc1ccc(OC)cc1COc1ccc(-c2nc3cc(C(=O)O)ccc3n2C2CCCCC2)cc1.CNC(=O)c1ccc(-c2ccc(Cl)cc2)c(COc2ccc(-c3nc4cc(C(=O)O)ccc4n3C3CCCCC3)cc2)c1.CNC(C)c1ccc2c(c1)nc(-c1ccc(OCc3ccccc3)cc1)n2C1CCCCC1.
What is the InChIKey of 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine?
The InChIKey is HVSWCARGAVCSRA-SADIJRGMSA-N. The full InChI is InChI=1S/C36H36ClN3O3.2C35H32ClN3O4.C31H34N2O4.C31H32N2O4.C29H33N3O/c1-2-20-38-29-15-18-32(24-8-13-28(37)14-9-24)27(21-29)23-43-31-16-10-25(11-17-31)35-39-33-22-26(36(41)42)12-19-34(33)40(35)30-6-4-3-5-7-30;1-37-34(40)24-11-17-30(22-7-13-27(36)14-8-22)26(19-24)21-43-29-15-9-23(10-16-29)33-38-31-20-25(35(41)42)12-18-32(31)39(33)28-5-3-2-4-6-28;1-22(40)37-28-14-17-31(23-7-12-27(36)13-8-23)26(19-28)21-43-30-15-9-24(10-16-30)34-38-32-20-25(35(41)42)11-18-33(32)39(34)29-5-3-2-4-6-29;2*1-3-7-21-10-16-27(36-2)18-24(21)20-37-26-14-11-22(12-15-26)30-32-28-19-23(31(34)35)13-17-29(28)33(30)25-8-5-4-6-9-25;1-21(30-2)24-15-18-28-27(19-24)31-29(32(28)25-11-7-4-8-12-25)23-13-16-26(17-14-23)33-20-22-9-5-3-6-10-22/h8-19,21-22,30,38H,2-7,20,23H2,1H3,(H,41,42);7-20,28H,2-6,21H2,1H3,(H,37,40)(H,41,42);7-20,29H,2-6,21H2,1H3,(H,37,40)(H,41,42);10-19,25H,3-9,20H2,1-2H3,(H,34,35);3,7,10-19,25H,4-6,8-9,20H2,1-2H3,(H,34,35);3,5-6,9-10,13-19,21,25,30H,4,7-8,11-12,20H2,1-2H3/b;;;;7-3+;.
What are the key properties of 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine?
2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine has a molecular weight of 3217.21 g/mol, XLogP of 48.60, 50 rotatable bonds, 9 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[[5-acetamido-2-(4-chlorophenyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(methylcarbamoyl)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;2-[4-[[2-(4-chlorophenyl)-5-(propylamino)phenyl]methoxy]phenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[[5-methoxy-2-[(E)-prop-1-enyl]phenyl]methoxy]phenyl]benzimidazole-5-carboxylic acid;1-cyclohexyl-2-[4-[(5-methoxy-2-propylphenyl)methoxy]phenyl]benzimidazole-5-carboxylic acid;1-[1-cyclohexyl-2-(4-phenylmethoxyphenyl)benzimidazol-5-yl]-N-methylethanamine is sourced from PubChem (CID 158601935), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).